首页> 外文期刊>International Journal of Chronic Obstructive Pulmonary Disease >Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI)
【24h】

Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI)

机译:慢性阻塞性肺病器械(EMSCI)清晨症状的心理计量学评价

获取原文
           

摘要

Background: Early morning respiratory symptoms impact quality of life and are often the most troublesome for patients with COPD. Reduction in symptoms and their impact are important treatment outcomes for COPD. The Early Morning Symptoms of COPD Instrument (EMSCI) is a daily diary designed to collect patients’ report of the occurrence, severity, and impact of morning COPD symptoms. Methods: To assess the psychometric properties of the EMSCI, a split-half sample of data from a COPD clinical trial where participants completed the EMSCI daily was used for conducting descriptive statistics, factor analyses, and Rasch model analyses to examine item performance and inform scoring. Once the final scoring algorithm was determined, data from the second split-half sample were used to examine the properties of the EMSCI. Test–retest reliability was assessed using intraclass correlation coefficient (ICC). Correlations with other study assessments were used to evaluate convergent and known-groups validity. Results: Data from 1,663 patients with COPD aged 40–93 years were analyzed. Factor analysis and Rasch analysis confirmed a one-factor structure for the 6 individual symptom items. Item analyses supported the generation of 4 scores. All scores demonstrated good test–retest reliability: 6-item symptom severity (ICC, 0.84); overall morning symptom severity (ICC, 0.84); activity limitation (ICC, 0.85); and rescue medication (ICC, 0.62). Significant correlations between EMSCI scores, St George’s Respiratory Questionnaire scores, and EXAcerbations of Chronic pulmonary disease Tool (EXACT)-Respiratory Symptoms scores supported the tool’s convergent validity. Significant differences ( p <0.0001) in all EMSCI domain scores were found between known-groups based on median split St George’s Respiratory Questionnaire and EXACT-Respiratory Symptoms scores. Conclusion: The EMSCI consists of 4 scores: 6-item symptom severity, overall symptom severity, activity limitation, and rescue medication. The EMSCI is a reliable and valid instrument for evaluating patients’ experience of early morning COPD symptoms.
机译:背景:清晨的呼吸道症状会影响生活质量,对于COPD患者而言通常是最麻烦的。减轻症状及其影响是COPD的重要治疗结果。 COPD仪器的清晨症状(EMSCI)是每日日记,旨在收集患者关于早晨COPD症状的发生,严重程度和影响的报告。方法:为了评估EMSCI的心理计量学特性,使用参与者每天完成EMSCI的COPD临床试验的一半数据样本进行描述性统计,因子分析和Rasch模型分析,以检查项目绩效并提供评分。确定最终评分算法后,将使用第二个半样本的数据来检查EMSCI的属性。使用组内相关系数(ICC)评估重测信度。与其他研究评估的相关性用于评估趋同性和已知群体的有效性。结果:分析了来自1663名40-93岁的COPD患者的数据。因子分析和Rasch分析证实了6个单独症状项目的单因子结构。项目分析支持生成4个分数。所有分数均表现出良好的再测信度:6项症状严重程度(ICC,0.84);总体早晨症状严重程度(ICC,0.84);活动限制(ICC,0.85);和抢救药物(ICC,0.62)。 EMSCI得分,圣乔治呼吸问卷调查得分和慢性肺疾病工具(EXACT)的症状-呼吸系统症状得分之间的显着相关性支持该工具的收敛有效性。根据中位数拆分的圣乔治呼吸问卷和精确呼吸症状分数,发现已知组之间所有EMSCI域分数均存在显着差异(p <0.0001)。结论:EMSCI包括4个评分:6个项目的症状严重程度,总体症状严重程度,活动受限和急救药物。 EMSCI是评估患者清晨COPD症状的可靠且有效的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号